End of grant evaluation: Ensuring access to the Hepatitis C (HCV) treatment revolution for HCV/HIV co-infected patients in LMICs

Hepatitis C diagnostics technology landscape – May 2019

Multi-disease diagnostics landscape for integrated management of HIV, HCV, TB and other coinfections

Hepatitis C medicines technology and market landscape

Expanding access to diagnosis and treatment of hepatitis C

Increasing awareness of hepatitis C treatment options

New diagnostics for hepatitis C